Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
H2020Докторантска мрежа2016–2021

HiPerNav · High Performance Soft-tissue Navigation

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2016-11-01 → 2021-04-30
Финансиране от ЕС
4 041 920 €
Участници
14
Схема
MSCA-ITN-ETN

Линиите свързват координатора с партньорите.

Накратко на български

Компютърно подпомогнатите системи за навигация при операции на черния дроб помагат за по-точното отстраняване на тумори. Това е важно, за да се запази максимално количество здрава тъкан и да се подобри прогнозата за оцеляване на пациентите.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

High Performance Soft-tissue Navigation

Liver resection is the treatment of choice in selected patients with primary liver cancer and hepatic colorectal metastases, even in recurrent cases, with 5-year survival rates of up to 58%. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue as possible. Due to technical and clinical difficulties there is an urgent need to increase the patient eligibility and improve the survival prognosis after liver interventions (resection or ablation). Objectives: The overall goal of HiPerNav is to successfully train and educate young researchers (ESRs) in the multidisciplinary field of image-guided interventions. The scientific and clinical goal is to further develop solutions for computer assisted and image guided surgical and interventional procedures for the treatment of primary and secondary liver cancer. It is aimed at improving eligibility and survival prognosis of cancer patients. The project is organized through a consortium comprising 5 European universities, 2 university hospitals, 2 research organizations and 5 industrial companies, whereas one SME. Oslo University Hospital is the coordinator. In total 16 young researchers (ESRs) will be financed through the project. The HiPerNav project aims to improve important bottlenecks in soft-tissue navigation: –effective pre-operative model and planning –accurate and fast intra-operative model update –accurate and fast model-to-patient registration –intuitive user-interaction and effective workflow –high performance computing by use of GPU The 14 organizations in the consortium are selected being one of the leading institutions within their field of expertise, and they are all selected to fill specific competences needed to meet the HiPerNav overall goal. The consortium partner organizations are: Oslo University Hospital, University Hospital Bern, NTNU, SINTEF, INRIA, University of Bern, University Paris13, University of Delft, University of Cordoba, CAScination, SIEMENS, NVIDIA, Yes!Delft and Innovation Norway. Conclusions of the action: ESRs received academic and industrial training in addition to strong carrier development. In collaboration, consortium further developed existing and found new technological solutions for soft-tissue navigation. Novel navigation workflows have been evaluated in pre-clinical and clinical trials. These achievements may in the future improve treatment of patient with lesion in the liver.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue as possible. Due to technical and clinical difficulties relatively low percentage of patients are eligible for resection. There is an urgent need to increase the patient eligibility and improve the survival prognosis after liver interventions. HiPerNav will train early stage researchers (biomedical engineers and medical doctors) to become international leading in key areas of expertise through a novel coordinated plan of individual research projects addressing specific bottlenecks in soft tissue navigation for improved treatment of liver cancer. The multi-disciplinary dialogue and work between clinicians and biomedical engineers is crucial to address these bottlenecks. By providing researchers with knowledge and training within specific topics from minimally invasive treatment, biomedical engineering, research methodologies, innovation and entrepreneurship, the link between academic research and industry will be strengthened. This allows for easy transfer of promising results from the research projects to commercially exploitable solutions. The global image guided surgery devices market is promising; it was valued at USD 2.76 billion in 2013 and is projected to expand 6.4% from 2014 to 2022 to reach USD 4.80 billion in 2022. The market for soft-tissue navigation is still in its infancy, mainly due to challenges in achieved accuracy for targeting deformable and moving organs. By providing multi-disciplinary training, the researchers in this consortium of international leading research institutions, universities and industry will initiate true translational research from academic theoretical ideas to the clinical testing of prototype, developed solutions and tools.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз